Bioinn to Distribute Courtagen's NGS Tests in Taiwan | GenomeWeb

NEW YORK (GenomeWeb) – Courtagen Life Sciences today announced a deal with Bioinn Molecular Diagnosis to provide Courtagen's clinical next-generation sequencing tests for neurological and metabolic disorders in Taiwan.

Courtagen's tests provide information on the genetic causes of disorders including epilepsy, intellectual disability, autism spectrum disorders, and mitochondrial dysfunction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.